Page 2 - Taiwanese (TAIEX) Pharmaceuticals & Biotech Stocks - Biggest Losers Today

UPDATED Apr 21, 2024

Explore the Taiwanese (TAIEX) Biggest Losers Today. These Pharmaceuticals & Biotech Stocks have seen the largest drop in Market Cap from the previous trading day.

121 companies
CompanyLast Price1D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

7607

DuoGenic StemCells
NT$32.00-3.3%n/aNT$977.7mn/an/an/an/a

6748

ACRO Biomedical
NT$37.35-1.3%33.4%NT$2.3bn/an/an/an/a

6973

U-Neuron Biomedical
NT$52.40-1.9%n/aNT$1.5bn/an/an/an/a

4120

Orient EuroPharma
NT$40.50-0.7%10.1%NT$3.5bn/aPE24.4xn/a2.5%

6945

AP Biosciences
NT$57.90-0.7%n/aNT$3.7bn/aPS116.2xn/an/a

4105

TTY Biopharm
NT$75.90-0.1%0%NT$18.9bNT$86.50PE16.7xE18.7%4.6%

4168

GlycoNex Incorporation
NT$25.20-0.8%-19.0%NT$2.7bn/aPS1077xn/a0%

1295

Synbio Tech
NT$72.30-1.0%n/aNT$2.2bn/an/an/an/a

4114

Synmosa Biopharma
NT$37.85-0.1%-12.5%NT$14.5bNT$36.00PE24.3xn/a1.6%

4194

Holy Stone Healthcare
NT$16.85-0.9%-55.9%NT$2.1bn/aPS8.7xn/an/a

6709

Advagene Biopharma
NT$16.70-1.8%-42.5%NT$891.4mn/aPB6.4xn/an/a

6810

Bio Preventive Medicine
NT$36.35-1.2%-5.0%NT$1.3bn/an/an/an/a

6549

TaiwanJ Pharmaceuticals
NT$12.05-1.6%-62.0%NT$905.2mn/aPS39.8xn/an/a

6814

Lukas Biomedical
NT$29.20-1.4%-22.8%NT$1.1bn/aPS4.6xn/an/a

4172

InnoPharmax
NT$14.60-1.0%-17.3%NT$1.4bn/aPS30.1xn/an/a

6677

Anxo Pharmaceutical
NT$44.95-0.6%-10.5%NT$2.5bn/aPE75.2xn/a0%

4131

NeoCore Technology
NT$30.15-1.1%7.3%NT$1.2bn/aPS18.4xn/an/a

3164

GenMont Biotech Incorporation
NT$21.95-0.7%-10.2%NT$1.9bn/aPE57.6xn/a3.2%

1780

Allied Biotech
NT$17.60-0.6%-7.6%NT$1.7bn/aPE11.7xn/a6.8%

6955

Bonraybio
NT$158.00-0.3%n/aNT$2.7bn/an/an/an/a

4111

Chi Sheng Pharma & Biotech
NT$25.70-0.6%-18.3%NT$1.5bn/aPE21.3xn/a3.9%

6794

UnicoCell Biomed
NT$84.90-0.1%11.0%NT$4.7bn/aPS192.3xn/an/a

6492

Senhwa Biosciences
NT$40.65-0.1%-21.2%NT$3.6bn/aPS3625.4xn/an/a

6936

Vetnostrum Animal Health
NT$36.50-0.1%0%NT$2.4bn/an/an/an/a
Page 2 of 6
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.